Catalyst
Slingshot members are tracking this event:
Ad Comm meeting Scheduled for March 29, 2016 to Review NUPLAZID (Pimavanserin) for the Treatment of Parkinson’s Disease Psychosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ACAD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 29, 2016
Occurred Source:
http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-newsArticle&ID=2151571
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Psychosis, Parkinson’s Disease, Nda, Nuplazid, Pimavanserin, Ad Comm
